ro's glp-1 supply tracker Ro launches the Both Ro and Hims offer
Description
Taking a GLP-1
A large new study found no link between semaglutide, the active ingredient in some GLP-1 drugs, and suicidal ideation.
Starting a GLP-1 without addressing hormonal optimization is leaving a major piece of the puzzle on the table for most active patients.
Pfizer is preparing for a consumer market for obesity drugs on par with the booming business it saw after it launched erectile dysfunction drug Viagra in 1998, CEO Albert Bourla said on Monday.
A closely watched pill from Novo Nordisk just scored an approval for slashing cardiovascular risks, while Mark Cuban gives Trump credit on drug prices.
Bob Gabbay, endocrinologist, researcher, and former Chief Scientific and Medical Officer of the American Diabetes Association, as he explores the most exciting topics and latest innovations in diabetes care
